Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Tighter Foreign Investment Control, Compulsory Licensing In The Offing Rupali Mukherjee & Prabhakar Sinha | TNN Mumbai: Government is considering to bring in tighter foreign investment control in the pharmaceutical sector and to implement compulsory licensing system to check high prices of patented drugs. It is also thinking to bring …
Trade agreements with stiff intellectual property protection requirements combined with buyouts of India’s top generics makers by multinationals threaten to deny affordable medicines to millions of poor. The cost of essential medicines is a major barrier to healthcare, writes LATHA JISHNU. But the Indian government is doing little to control …
In an ideal market economy competition lowers prices of consumer goods. It is just the opposite in the case of pharmaceutical products. More expensive brands sell more. Take Cyclovir, an ointment for treating skin infection caused by herpes. Its therapy cost (cost of one course) is Rs 812, while a …
Patients visiting public health centres in Nagaur district in central Rajasthan these days rarely buy branded drugs. Doctors direct them to the government- run generic medicine stores (GMS) where quality drugs are available at low cost. The district administration of Nagaur has managed to free the public health system from …
Bindeshwari, a scrap dealer in Punjab’s Ludhiana district, was asked to buy Cefzy-250 by the doctor treating his wife. She had delivered a baby in the government civil hospital in June-end. The chemist at the hospital’s Jan Aushadhi Store gave Bindeshwari Ceftazidime, a generic version of Cefzy- 250; both drugs …
HEALTHCARE activists plan to take union health ministry and the chemical & fertilizers ministry to the Supreme Court (SC) for failing to regulate prices of essential drugs, seven years after the apex court asked them to do so.
Chennai: The Government of India has incurred a loss of more than Rs 116 crore by keeping three public sector vaccine labs closed for two years, government audits and RTI applications have revealed. While the government had to spend an additional Rs 40 crore to purchase BCG, DPT and TT …
LUPIN Limited and Ranbaxy Laboratories along with its parent company Daiichi Sankyo have slapped patent infringement charges against each other to stop one another from launching low-cost versions of their respective original drugs in the US. Last Wednesday, Lupin sued Ranbaxy after the latter sought American drug regulator
New Delhi: The parliamentary standing committee on health and family welfare has suggested measures like increasing the number of drugs under price control, a blanket cap on profit margins and promoting the use of generic drugs to make drugs more affordable and accessible to the common man. In a report …
India is these days relying on imports to meet the demand for a plant extract valued for its medicinal properties. Guggal or Commiphora wightii grows in the wild in the arid and semi-arid regions of Pakistan and northern India; its resin, guggal-gum, is prescribed in Ayurveda for heart ailments, obesity …
New Delhi: The nation has developed an indigenous swine flu detection kit, which comes close on the heels of an homegrown swine flu vaccine. As the country reels under a fresh H1N1 swine flu outbreak
What is technology transfer and what does it need to succeed? Various factors concerning the scientist, the academic institution, a fresh entrepreneur or an existing company, government policies and the environment contribute to greater efficiency in transferring technologies from academia to industry. These factors are discussed here with reference to …
Rupali Mukherjee | TNN New Delhi: The US Food and Drug Administration (FDA) has directed pharma biggie GlaxoSmithKline to stop enrolling new subjects worldwide for conducting safety studies of controversial diabetes pill, Rosiglitazone (Avandia) till regulators decide whether the drug will be banned. In India, at least 20 cities including …
There is more to combating HIV in the developing world than providing affordable drugs. T. V. Padma looks at the innovative new strategies being employed.
SEVERAL industrialized countries are negotiating a treaty that could deny developing countries access to low-cost medicines, making them dependent on expensive patented drugs. The pact is very likely to go further than the World Trade Organization’s (WTO’s) trademark- related arrangements by branding any item suspected of violating patents as counterfeit. …
